A groundbreaking shift in Canadian drug policy has happened, as the government announce the use of psilocybin mushrooms for therapeutic purposes. Before this, these substances were strictly restricted, but a growing body of evidence suggests they could offer benefits for mental health conditions like PTSD. The new policy represents a key step towar